Discover 2,414 paid clinical trials in Bethesda, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,414
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
for
Gastric Adenocarcinoma,
Location: Baltimore MD, Philadelphia PA, New Brunswick NJ,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT07001748
Phase2, Phase3, Recruiting
Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver Impairment
for
Advanced or Metastatic Solid Tumor, Liver Failure
Location: Baltimore MD, Newark DE, Houston TX, San Antonio TX
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT04617522
Phase1, Recruiting
Working Memory and Physical Exercise Training in Patients With Mild Cognitive Impairment
for
Mild Cognitive Impairment
Location: Baltimore MD
Sponsor: University of Maryland, Baltimore
Sex: All
Age: 50 - 70+
Code: NCT05948930
Recruiting
The CREST-2 Registry
for
Carotid Artery Diseases
Location: Baltimore MD
Sponsor: University of Maryland, Baltimore
Sex: All
Age: 18 - 70+
Code: NCT02240862
Recruiting
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
for
Hepatitis
Location: Baltimore MD, Hershey PA, Richmond VA,
Sponsor: Bausch Health Americas, Inc.
Sex: All
Age: 18+
Code: NCT07428538
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
for
Multiple Myeloma, Secondary Immunodeficiency
Location: Baltimore MD, Albany NY, Detroit MI, Montreal,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06980480
Phase3, Recruiting
A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Baltimore MD, New Haven CT, Boston MA, Milwaukee WI,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT07226349
Phase1, Recruiting
Study to Evaluate Adenosine 2A Receptor Agonist (Regadenoson) in Patients Undergoing Lung Transplantation
for
Lung Transplant
Location: Baltimore MD
Sponsor: Christine Lau, MD
Sex: All
Age: 18 - 70+
Code: NCT03072589
Phase1, Recruiting
Is Physical Therapy Clearance Before Arthroplasty Home Discharge Necessary?
for
Physical Therapy, Total Joint Arthroplasty, Same-day Discharge
Location: Baltimore MD
Sponsor: University of Maryland, Baltimore
Sex: All
Age: 18 - 70+
Code: NCT05858086
Recruiting
Genomic Predictors of Recurrent Pregnancy Loss
for
Recurrent Pregnancy Loss
Location: Baltimore MD, Hershey PA, New York NY, New Haven CT,
Sponsor: Yale University
Sex: All
Age: 18 - 50
Code: NCT05444283
Recruiting
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
for
Leukemia, Myeloid, Chronic, Myeloid Leukemia,
Location: Baltimore MD, Cleveland OH, Toronto, Augusta GA,
Sponsor: Ascentage Pharma Group Inc.
Sex: All
Age: 18+
Code: NCT04260022
Phase1, Recruiting
Testing How the Body Responds to the Drug CBX-12 in Patients With Advanced Solid Cancers
for
Advanced Malignant Solid Neoplasm,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05691517
Phase1, Recruiting
CBT-CP for Veterans With SMI
for
Chronic Pain, Schizophrenia, Psychotic Disorders,
Location: Baltimore MD
Sponsor: VA Office of Research and Development
Sex: All
Age: 18+
Code: NCT06758414
Recruiting
Hyperpolarized 13C-pyruvate Metabolic MRI With Traumatic Brain Injury
for
Traumatic Brain Injury, Subarachnoid Hemorrhage
Location: Baltimore MD
Sponsor: University of Maryland, Baltimore
Sex: All
Age: 18 - 70+
Code: NCT06103201
Phase1, Recruiting
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
for
Renal Cell Carcinoma (RCC),
Location: Baltimore MD, Hershey PA, Charlottesville VA,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT05176483
Phase1, Recruiting
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD